![](/img/cover-not-exists.png)
Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis
Elenir B. C. Avritscher, Scott B. Cantor, Ya-Chen T. Shih, Carmelita P. Escalante, Edgardo Rivera, Linda S. EltingVolume:
12
Language:
english
Pages:
6
DOI:
10.1007/s00520-004-0597-2
Date:
July, 2004
File:
PDF, 154 KB
english, 2004